Driving scientific engagement, qualified opportunities, and field activation across key European biotech hubs
A US-based contract development and manufacturing organization (CDMO), known for its innovation in nucleic acid synthesis and mRNA capping technologies, was expanding its footprint into Europe. The company supports a wide range of therapeutic, vaccine, and diagnostic programs globally, and is recognized for delivering customized solutions to biotech and biopharma clients. To accelerate its commercial momentum in Europe, the company turned to Novoptim for a tailored, science-driven marketing strategy designed to increase visibility, foster meaningful engagement, and activate a newly established sales team.
To support its European expansion, the company needed to increase brand visibility and establish credibility in a fragmented and highly competitive CDMO landscape. Success would depend on effectively engaging both scientific and commercial stakeholders, while also gaining a deeper understanding of customer expectations and market dynamics. At the same time, the company’s newly formed European sales team required structured marketing support, market intelligence, and a pipeline of qualified opportunities to drive early business development success.
Novoptim deployed its Marketing “à la Carte” service to deliver a customized engagement strategy aligned with the client’s expansion goals. The initiative combined strategic planning with hands-on execution to raise visibility, generate market insights, and support early commercial traction. A core component of the program was a six-city seminar series held across key European biotech hubs, designed to initiate scientific dialogue and position the company within the mRNA and CDMO ecosystem. In parallel, Voice of Customer interviews were conducted to clarify buyer expectations and refine messaging. These insights helped guide content development and inform targeted outreach. To further support the client’s newly established sales team, Novoptim activated complementary activities including Lunch & Learns, conference participation, and marketing automation. This integrated approach enabled consistent engagement with high-value prospects and laid the groundwork for sustained commercial momentum.
The six-city seminar series attracted 245 registrants and 149 in-person participants, generating $7.2 million in qualified sales opportunities. The initiative significantly elevated the client’s brand visibility and positioning across the European mRNA and CDMO markets. Through targeted content, refined messaging, and strategic in-person engagement, Novoptim helped activate the sales team and drive qualified interest. Beyond these immediate results, the program laid the foundation for a scalable commercial approach, combining market insight, audience-specific communication, and integrated field execution to support long-term growth across the region.
Whether you’re entering the market or scaling your presence, we’re here to turn your innovation into commercial success.
